72 related articles for article (PubMed ID: 9213775)
1. Residual clones in childhood leukemia.
Loscalzo CP
N Engl J Med; 1997 Jul; 337(1):50; author reply 51. PubMed ID: 9213775
[No Abstract] [Full Text] [Related]
2. Residual clones in childhood leukemia.
Dibenedetto SP; Schilirò G
N Engl J Med; 1997 Jul; 337(1):50; author reply 51. PubMed ID: 9213774
[No Abstract] [Full Text] [Related]
3. Predictive value of flow cytometric minimal residual disease analysis in childhood acute lymphoblastic leukaemia at the end of remission induction therapy: results from a single UK centre.
Motwani J; Jesson J; Sturch E; Jones S; Eyre L; Short P; Davies P; Williams MD; Darbyshire PJ; Hill FG; Lawson S
Br J Haematol; 2009 Jan; 144(1):133-5. PubMed ID: 19016737
[No Abstract] [Full Text] [Related]
4. Late relapse of childhood acute lymphoblastic leukemia and pcr-monitoring of minimal residual disease: how much time can elapse between "molecular" and clinical relapse?
Aricò M; Germano G; del Giudice L; Ziino O; Locatelli F; Basso G
Haematologica; 2002 Apr; 87(4):ELT19. PubMed ID: 11940504
[No Abstract] [Full Text] [Related]
5. Residual clones in childhood leukemia.
Rabkin CS; Müller J; Goedert JJ
N Engl J Med; 1997 Jul; 337(1):50-1. PubMed ID: 9213776
[No Abstract] [Full Text] [Related]
6. Eliminating a gold standard in childhood acute lymphoblastic leukemia?
Raetz EA; Carroll WL
Pediatr Blood Cancer; 2006 Sep; 47(3):242-4. PubMed ID: 16421903
[No Abstract] [Full Text] [Related]
7. Eradication of residual bcr-abl-positive clones by inducing graft-versus-host disease after allogeneic stem cell transplantation in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Matsue K; Tabayashi T; Yamada K; Takeuchi M
Bone Marrow Transplant; 2002 Jan; 29(1):63-6. PubMed ID: 11840146
[TBL] [Abstract][Full Text] [Related]
8. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
[TBL] [Abstract][Full Text] [Related]
9. Use of molecular techniques to confirm true re-emergence of the original clone and to track minimal residual disease in a case of late extramedullary relapse of childhood acute lymphoblastic leukemia.
Valetto A; Anselmi G; Scuderi F; Lanciotti M; Chiesa V; Dini G
Haematologica; 2000 Oct; 85(10):1102-3. PubMed ID: 11025609
[No Abstract] [Full Text] [Related]
10. PCR detection of clonal IgH and TCR gene rearrangements at the end of induction as a non-remission criterion in children with ALL: comparison with standard morphologic analysis and risk group classification.
Scrideli CA; Queiroz RG; Bernardes JE; Valera ET; Tone LG
Med Pediatr Oncol; 2003 Jul; 41(1):10-6. PubMed ID: 12764736
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic value of both detection of lymphoblasts in the period of early treatment and minimal residual disease in childhood acute lymphoblastic leukemia].
Tie LJ; Gu LJ; Song DL; Jiang LM; Xue HL; Tang JY; Dong L; Pan C; Chen J; Ye H; Wang YP; Chen J
Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):6-9. PubMed ID: 15946500
[TBL] [Abstract][Full Text] [Related]
12. Integrating molecular information into treatment of childhood acute lymphoblastic leukemia--a perspective from the BFM Study Group.
Stanulla M; Cario G; Meissner B; Schrauder A; Möricke A; Riehm H; Schrappe M
Blood Cells Mol Dis; 2007; 39(2):160-3. PubMed ID: 17532236
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group.
Bader P; Kreyenberg H; Henze GH; Eckert C; Reising M; Willasch A; Barth A; Borkhardt A; Peters C; Handgretinger R; Sykora KW; Holter W; Kabisch H; Klingebiel T; von Stackelberg A;
J Clin Oncol; 2009 Jan; 27(3):377-84. PubMed ID: 19064980
[TBL] [Abstract][Full Text] [Related]
14. [Cord blood transplantation with two mismatched HLA loci in a child with acute lymphoblastic leukemia in second remission: follow-up of minimal residual disease using a clone-specific probe].
Sato H; Goi K; Takahashi K; Nemoto A; Uno K; Inukai T; Sugita K; Nakazawa S
Rinsho Ketsueki; 2001 Aug; 42(8):633-8. PubMed ID: 11579503
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic transplantation for childhood ALL.
Mehta PA; Davies SM
Bone Marrow Transplant; 2008 Jan; 41(2):133-9. PubMed ID: 17994118
[TBL] [Abstract][Full Text] [Related]
16. Early resistance to therapy during induction in childhood acute lymphoblastic leukemia.
Brisco MJ; Sykes PJ; Dolman G; Hughes E; Neoh SH; Peng L; Snell LE; Toogood IR; Rice MS; Morley AA
Cancer Res; 2000 Sep; 60(18):5092-6. PubMed ID: 11016634
[TBL] [Abstract][Full Text] [Related]
17. Molecular detection of minimal residual disease is associated with early relapse in adult acute lymphoblastic leukemia.
Specchia G; Liso A; Pannunzio A; Albano F; Mestice A; Pastore D; Liso V
Haematologica; 2004 Oct; 89(10):1271-3. PubMed ID: 15477219
[TBL] [Abstract][Full Text] [Related]
18. Post-induction residual disease in translocation t(12;21)-positive childhood ALL.
Seyfarth J; Madsen HO; Nyvold C; Ryder LP; Clausen N; Jonmundsson GK; Wesenberg F; Schmiegelow K
Med Pediatr Oncol; 2003 Feb; 40(2):82-7. PubMed ID: 12461790
[TBL] [Abstract][Full Text] [Related]
19. Cytomorphological characteristics of lymphocytes in children during remission of acute lymphoblastic leukaemia lasting many years.
Kopeć-Szlezak J; Rokicka-Milewska R; Grabarczyk M; Skrobowska-Woźniak A
Mater Med Pol; 1988; 20(3):168-70. PubMed ID: 3244289
[No Abstract] [Full Text] [Related]
20. [Minimal residual disease in childhood acute lymphoblastic leukemia: diagnosis of the 21 century].
Szczepański T; Sońta-Jakimczyk D; Van Dongen JJ
Przegl Lek; 2003; 60 Suppl 5():1-4. PubMed ID: 14574999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
